Drug treatment programs' HCV service delivery to their HCV positive clients

References

• Alter MJ, Moyer LA. The importance of preventing hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998; 18(Suppl 1): S6–S10
   Google Scholar
• Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine 1999; 341: 556–562
   Google Scholar
• Astone J, Strauss SM, Vassilev ZP, Des Jarlais DC. Provision of hepatitis C education in a nationwide sample of drug treatment programs. Journal of Drug Education 2003; 33: 107–117
   Google Scholar
• Backmund M, Meyer K, Von Zielonka M, Eichenlaub D. Treatment of hepatitis C infection in injection drug users. Hepatology 2001; 34: 188–193
   Google Scholar
• Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47: 1–39
   Google Scholar
• Centers for Disease Control and Prevention. Hepatitis C Fact Sheet. 2003, Retrieved January 22, 2005 from www.cdc.gov/hepatitis
   Google Scholar
• Clapp JD. Organizational factors related to AIDS/HIV education in outpatient substance abuse treatment units. Journal of Health and Social Policy 1998; 9: 1–13
   Google Scholar
• D’Aunno T, Vaughn TE, McElroy P. An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. Journal of Health and Social Behavior 1999; 40: 175–192
   Google Scholar
• Edlin BR. Prevention and treatment of hepatitis C in injection drug users. Hepatology 2002; 36(5 Suppl 1): S210–S219
   Google Scholar
• Edlin BR, Seal KH, Lorvick J, Kral AH, Ciccarone DH, Moore LD, et al. Is it justifiable to withhold treatment for hepatitis C from illicit drug users?. New England Journal of Medicine 2001; 345: 211–215
   Google Scholar
• Friedmann PD, Alexander JA, D'Aunno TA. Organizational correlates of access to primary care and mental health services in drug abuse treatment units. Journal of Substance Abuse Treatment 1999; 16: 71–80
   Google Scholar
• Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998; 18(Suppl 1): S11–S19
   Google Scholar
• Hagan H, McGough JP, Thiede H, Weiss S, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. American Journal of Epidemiology 1999; 149: 203–213
   Google Scholar
• Hagan H, Thiede H, Weiss HS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 2001; 91: 42–46
   Google Scholar
• Koch M, Banys P. Liver transplantation and opioid dependence. The Journal of the American Medical Association 2001; 285: 1056–1058
   Google Scholar
• McCarthy JJ, Flynn N. Hepatitis C in methadone maintenance patients: Prevalence and public policy implications. Journal of Addictive Diseases 2001; 20: 19–31
   Google Scholar
• McCoy HV, Messiah SE, Zhao W. Improving access to primary health care for chronic drug abusers: An innovative systematic intervention for providers. Journal of Behavioral Health Services Research 2002; 29: 445–457
   Google Scholar
• McMahon J, Tortu S. A potential hidden source of hepatitis C infection among non-injecting drug users. Journal of Psychoactive Drugs 2003; 35: 455–460
   Google Scholar
• Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Reports 1998; 113(Suppl 1): 97–106
   Google Scholar
• Pearlman BL. Hepatitis C infection: A clinical review. Southern Medical Journal 2004; 97: 364–373
   Google Scholar
• Pratt C.-C. N. U., Paone D, Carter BJ, Layton MC. Hepatitis C screening and management practices: A survey of drug treatment and syringe exchange programs in New York City. American Journal of Public Health 2002; 92: 1254–1256
   Google Scholar
• Rosenberg SD, Goodman LA, Osher FC. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health 2001; 91: 42–46
   Google Scholar
• Rosenblum A, Nuttbrock L, McQuistion HL, Magura S, Joseph H. Hepatitis C and substance use in a sample of homeless people in New York City. Journal of Addictive Diseases 2001; 20: 15–25
   Google Scholar
• Sorensen JL, Masson CL, Perlman DC. HIV/hepatitis prevention in drug abuse treatment programs: Guidance from research. Science and Practice Perspectives 2002; 1: 4–11
   Google Scholar
• Stein MD, Maksad J, Clarke J. Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence 2001; 61: 211–215
   Google Scholar
• Stephenson J. Former addicts face barriers to treatment for HCV. The Journal of the American Medical Association 2001; 285: 118–126
   Google Scholar
• Strauss SM, Astone JM, Des Jarlais DC, Hagan H. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. Drug and Alcohol Dependence 2004a; 73: 227–236
   Google Scholar
• Strauss SM, Astone JM, Hagan H, Des Jarlais DC. The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. Journal of Urban Health 2004b; 81: 38–47
   Google Scholar
• Strauss SM, Astone J, Vassilev ZP, Des Jarlais DC, Hagan H. Gaps in the drug-free and methadone treatment program response to hepatitis C. Journal of Substance Abuse Treatment 2003; 24: 291–297
   Google Scholar
• Strauss SM, Falkin GP, Vassilev Z, Des Jarlais DC, Astone J. A nationwide survey of hepatitis C services provided by drug treatment programs. Journal of Substance Abuse Treatment 2002; 22: 55–62
   Google Scholar
• Sylvestre DL. Treating hepatitis C in methadone maintenance patients: An interim analysis. Drug and Alcohol Dependence 2002; 67: 117–123
   Google Scholar
• Tortu S, Neaigus A, McMahon J, Hagen D. Hepatitis C among non-injecting drug users: A report. Substance Use and Misuse 2001; 36: 523–534
   Google Scholar
• Van Ameijden EJ, van den Hoek JA, Mientjes GH, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. European Journal of Epidemiology 1993; 9: 255–262
   Google Scholar
• Winstock AR, Sheridan J, Lovell S, Farrell M, Strang J. National survey of hepatitis testing and vaccination services provided by drug services in England and Wales. European Journal of Clinical Microbiology and Infectious Diseases 2000; 19: 823–828
   Google Scholar
• Zweben JE. Hepatitis C: Education and counseling issues. Journal of Addictive Diseases 2001; 20: 33–42
   Google Scholar